<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Psychiatry Presentations</title>
<copyright>Copyright (c) 2013 Western University All rights reserved.</copyright>
<link>http://ir.lib.uwo.ca/psychiatrypres</link>
<description>Recent documents in Psychiatry Presentations</description>
<language>en-us</language>
<lastBuildDate>Sun, 27 Jan 2013 00:54:56 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Beyond Early Intervention</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/40</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/40</guid>
<pubDate>Thu, 20 Jan 2011 17:41:49 PST</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Current Understanding and Pharmacological Management of Suicide Behavior in Clinical Setting</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/39</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/39</guid>
<pubDate>Mon, 03 Jan 2011 15:15:37 PST</pubDate>
<description>
	<![CDATA[
	<p>This presentation addresses these issues:<br />  • Nature of problem in clinical settings<br /> • Current understanding about suicide behavior (neurobiology)<br /> • What can be done to deal with suicide in clinical settings<br /> • Pharmacological management</p>

	]]>
</description>

<author>Amresh Shrivastava</author>


</item>






<item>
<title>Psychoendocrinology (Thyroid Hormone) and Early Psychosis: Preliminary Findings</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/38</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/38</guid>
<pubDate>Fri, 18 Jun 2010 18:06:58 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Serum Lipids and Suicidality in Early Psychosis: Is There a Connection? A Preliminary Study</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/37</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/37</guid>
<pubDate>Fri, 18 Jun 2010 17:57:25 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Enhancing Risk Assessment across Mental Health Services</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/36</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/36</guid>
<pubDate>Tue, 08 Jun 2010 17:16:24 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Should &apos;Risk Syndrome of Psychosis&apos; Be Included in DSM V as a Diagnosis? A Road towards Preventive Psychiatry</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/35</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/35</guid>
<pubDate>Tue, 08 Jun 2010 17:00:18 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Antipsychotics and Outcome in Schizophrenia</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/34</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/34</guid>
<pubDate>Tue, 08 Jun 2010 16:48:48 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Predictors and Characteristics of Response and Nonresponse: A Ten Year Follow-Up of First Episode Schizophrenia in Mumbai</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/33</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/33</guid>
<pubDate>Tue, 16 Mar 2010 11:38:27 PDT</pubDate>
<description>
	<![CDATA[
	<p>▪ It is not clearly known what predicts good long-term outcome in first episode schizophrenia and what the characteristics are that differentiate patients who do and do not show good response</p>
<p>▪ We attempted to find the characteristics and predictors of good out-come for patients who presented with severe psychopathology and were hospitalized in their first episode psychosis in a tertiary psychiatric hospital in the city of Mumbai</p>
<p>▪ 101 patients of first episode schizophrenia were assessed at hospitalization, and reassessed at ten years</p>
<p>▪ The data was analyzed on 13 outcome parameters for predictors and characteristics of good outcome, using the SAS system of statistical analysis</p>
<p>▪ 61 of 101 patients showed good outcome on the CGIS after ten years</p>
<p>▪ Predictors of good recovery were high baseline positive symptoms and low negative symptoms, higher anxiety-depressive symptoms, lower level of depressive symptoms, lower level of aggression, higher work performance and ability to live independently.</p>
<p>▪ Characteristics of non-recovered patients showed higher extra pyramidal symptoms, severe aggressive symptoms, higher frequency of disorganization symptoms at baseline and higher level of family burden at the end of the term</p>
<p>▪ Our study shows reasonably good outcome [61.7%] in first episode-hospitalized patients</p>
<p>▪ Good outcome correlated with severity of positive symptoms, level of work function and ability to live independently at baseline</p>

	]]>
</description>

<author>Amresh Shrivastava et al.</author>


</item>






<item>
<title>Do Atypical Antipsychotics Differ in Determining Long-term Outcome of First Episode Schizophrenia? A Naturalistic Outcome Study in India</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/32</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/32</guid>
<pubDate>Fri, 12 Feb 2010 18:31:58 PST</pubDate>
<description>
	<![CDATA[
	<p>Antipsychotic medications form the mainstream of treatment in schizophrenia.  These drugs have several short term as well long term advantage.  It is not known if atypical antipsychotics have the long-term effect in improving outcome and meeting expectations (1,2,3).  The present study examined usage and association of antipsychotics drugs with clinical outcome a long-term naturalistic study.</p>

	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Early Psychosis: A Bridge to Future</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/31</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/31</guid>
<pubDate>Wed, 04 Nov 2009 17:56:17 PST</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Early Psychosis: A Novel Gateway for Suicide Prevention</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/30</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/30</guid>
<pubDate>Thu, 22 Oct 2009 11:11:03 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Coercion and Psychiatric Rehabilitation: A Conceptual and Ethical Analysis</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/29</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/29</guid>
<pubDate>Thu, 15 Oct 2009 15:14:48 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Abraham Rudnick</author>


</item>






<item>
<title>Clinical Interview for Psychiatric Assessment</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/28</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/28</guid>
<pubDate>Fri, 02 Oct 2009 17:59:30 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>First Episode Is the Best Episode: Lessons and Limitations in Duration of Untreated Psychosis (DUP) and Outcome in Schizophrenia</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/27</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/27</guid>
<pubDate>Fri, 25 Sep 2009 19:46:07 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Early intervention in psychosis is an opportunity. Research ahs shown that if any thing community members can do to prevent psychosis is to report early. This has opened newer vistas for understanding the complexity of brain and behaviour in schizophrenia. At the same time it has raised the bar of expectations regarding its correlation to outcome. It finally narrows down to meaningful public campaign for awareness, which will decide success of research to clinics in schizophrenia management. Duration of untreated psychosis (DUP) has emerged as a reliable predictor of outcome and provides credence to development of early intervention services. It is not quite clear if DUP works in isolation and what other factors along with DUP would determine outcome long-term outcome of schizophrenia is multifactorial in nature. The present study examines effect of DUP on outcome of schizophrenia</p>
<p>Method: we conducted a ten years follow up study of first episode hospitalized DSM III-R schizophrenia and correlated multiple outcome criteria with DUP at Mumbai. We carefully determined onset of psychosis using criteria for appearance of positive symptoms, negative symptoms or significant social decline. Data was analyzed using SAS.</p>
<p>Results: we analyzed 101 patients available at ten years. We found that mean DUP was higher for group, which showed Clinical recovery on GCIS [14.0(SD=8.0) months for recovered & 10.8 (SD=5.7) months in nonrecovered group p=0.091]. There is a significant difference in favour of DUP≤6 months in terms of subscales of PANSS; However DUP was not found to be significantly associated with the end point parameters of good clinical or social outcome.</p>
<p>Conclusion: We find that DUP is just one factor in determinants of outcome. Several other psychopathological & phenomenological factors collectively play a role in determining outcome. Future research needs to be directed towards combination of determinants of outcome in early intervention of psychosis.</p>

	]]>
</description>

<author>Amresh Srivastava et al.</author>


</item>






<item>
<title>Cannabis &amp; Psychosis: The Interface Emerging Frontiers for Research</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/26</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/26</guid>
<pubDate>Fri, 04 Sep 2009 18:29:03 PDT</pubDate>
<description>
	<![CDATA[
	<p>INTRODUCTION: CANNABIS CONTINUES TO AFFECT MENTAL HEALTH. ITS ABUSE IS ON RISE GLOBALLY. IN CANADA A RISE BY 30% IN LAST TEN YEARS HAS BEEN OBSERVED IN HIGH SCHOOL STUDENTS. INTERRELATIONSHIP OF CANNABIS WITH PSYCHOSIS AND SCHIZOPHRENIA IS A COMPLEX ONE. CANNABIS IS HIGHLY COMORBID WITH PSYCHOSIS, & RELATED TO FUNCTIONAL DISABILITY AND OUTCOME. IT POSES SEVERAL CHALLENGES IN UNDERSTANDING CAUSAL RELATIONSHIP FOR COMORBIDITY, UNDERLYING NEUROCHEMICAL BASIS AND SPECIFICS OF SERVICE DEVELOPMENT. PREVALENCE OF CANNABIS VARIES FROM 20 TO 50% EARLY PSYCHOSIS. OBJECTIVE OF THIS PAPER IS TO REVIEW AVAILABLE LITERATURE TO IDENTIFY CHALLENGES FOR NEWER TARGETS OF RESEARCH AND PREVENTIVE MEASURES.</p>
<p>METHOD: RECENT LITERATURE FROM ELECTRONIC DATA BASE SEARCH IDENTIFIES ROLE AND RELATIONSHIP OF CANNABIS AND PSYCHOSIS.</p>
<p>RESULTS. CANNABIS IS A RISK FACTOR FOR BOTH PSYCHOSIS AND SCHIZOPHRENIA & APPEARS TO HAVE CAUSAL RELATIONSHIP FOR EARLY AND LATERAGE PSYCHOSIS. MOOD SYMPTOMS ARE ALSO SIGNIFICANT BUT LESS RECOGNIZED. UNDERSTANDINGS OF THE PROCESS AND CAUSES HAVE SIGNIFICANTLY ADVANCED WITH DISCOVERY OF CANNABINOID RECEPTORS AND ENDOGENOUS CANNABINOIDS. IT IS CLEAR THAT CANNABIS INCREASES BRAIN VULNERABILITY, CAUSES POORER OUTCOME AND MORE SIDE EFFECTS. CANNABIS CAUSES COGNITIVE DYSFUNCTION THAT PERHAPS WORKS AS A COMMON DENOMINATOR FOR THE RISK-VULNERABILITY. IT APPEARS TO HAVE INDEPENDENT GENETIC COMPONENT RELATED TO DISRUPTION IN NEUROTRANSMISSION AFFECTING NEURONAL PLASTICITY. MUCH LESS ATTENTION HAS BEEN PAID IN DEVELOPING SERVICES TARGETED TOWARDS HARM REDUCTION AND DEVELOPING THERAPEUTICS.</p>
<p>CONCLUSION. CANNABIS IS POTENTIAL RISK FACTOR FOR POORER OUTCOME IN PSYCHOSIS. NEW BIOLOGICAL AND SOCIAL SERVICE INITIATIVES WILL ADD VALUE TO EARLY PSYCHOSIS PROGRAMS.</p>

	]]>
</description>

<author>Amresh Shrivastava</author>


</item>






<item>
<title>Should Schizoaffective Disorder Be Dropped from DSM V</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/25</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/25</guid>
<pubDate>Mon, 31 Aug 2009 17:28:58 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Catatonia Yesterday, Today, Tomorrow</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/24</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/24</guid>
<pubDate>Fri, 28 Aug 2009 17:27:53 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Switching and Selecting Atypical Antipsychotic Drugs: Paliperidone</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/23</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/23</guid>
<pubDate>Fri, 28 Aug 2009 17:27:52 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Schizophrenia: General Findings and Current Status</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/22</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/22</guid>
<pubDate>Fri, 28 Aug 2009 17:27:52 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>






<item>
<title>Treatment Resistant Depression</title>
<link>http://ir.lib.uwo.ca/psychiatrypres/21</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/psychiatrypres/21</guid>
<pubDate>Fri, 28 Aug 2009 17:27:51 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Amresh Srivastava</author>


</item>





</channel>
</rss>
